Skip to main content
. 2014 Dec 18;7(1):138–151. doi: 10.4161/19420862.2014.985993
  KD1 (nM) ka1 (× 105 M−1s−1) kd1 (× 10−2 s−1) KD2 (nM) ka2 (× 105 M−1s−1) kd2 (× 10−2 s−1)
Adalimumab 8.77 (± 3.88) 9.06 (± 2.60) 0.73 (± 0.18) 467 (± 312) 3.62 (± 1.49) 14.1 (± 7.35)
PSV#1 3.14 (± 1.42) 17.50 (± 7.75) 0.48 (± 0.11) 128 (± 25) 10.4 (± 3.58) 12.6 (± 6.47)
PSV#2 6.61 (± 2.11) 6.16 (± 1.54) 0.39 (± 0.07) 123 (± 7.09) 8.38 (± 0.56) 10.3 (± 5.04)
PSV#3 10.2 (± 0.28) 5.01 (± 2.17) 0.51 (± 0.21) 115 (± 7.07) 13.2 (± 0.85) 15.2 (± 0.01)